Literature DB >> 17726406

European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).

Ian Graham1, Dan Atar, Knut Borch-Johnsen, Gudrun Boysen, Gunilla Burell, Renata Cifkova, Jean Dallongeville, Guy De Backer, Shah Ebrahim, Bjørn Gjelsvik, Christoph Herrmann-Lingen, Arno Hoes, Steve Humphries, Mike Knapton, Joep Perk, Silvia G Priori, Kalevi Pyorala, Zeljko Reiner, Luis Ruilope, Susana Sans-Menendez, Wilma Scholte Op Reimer, Peter Weissberg, David Wood, John Yarnell, Jose Luis Zamorano, Edmond Walma, Tony Fitzgerald, Marie Therese Cooney, Alexandra Dudina, Alex Vahanian, John Camm, Raffaele De Caterina, Veronica Dean, Kenneth Dickstein, Christian Funck-Brentano, Gerasimos Filippatos, Irene Hellemans, Steen Dalby Kristensen, Keith McGregor, Udo Sechtem, Sigmund Silber, Michal Tendera, Petr Widimsky, Jóse Luis Zamorano, Attila Altiner, Enzo Bonora, Paul N Durrington, Robert Fagard, Simona Giampaoli, Harry Hemingway, Jan Hakansson, Sverre Erik Kjeldsen, Mogens Lytken Larsen, Giuseppe Mancia, Athanasios J Manolis, Kristina Orth-Gomer, Terje Pedersen, Mike Rayner, Lars Ryden, Mario Sammut, Neil Schneiderman, Anton F Stalenhoef, Lale Tokgözoglu, Olov Wiklund, Antonis Zampelas.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17726406     DOI: 10.1097/01.hjr.0000277984.31558.c4

Source DB:  PubMed          Journal:  Eur J Cardiovasc Prev Rehabil        ISSN: 1741-8267


× No keyword cloud information.
  123 in total

1.  Hypertension risk assessment in the largest ethnic groups in Jordan.

Authors:  Kawkab Shishani; Rana Dajani; Yousef Khader
Journal:  J Immigr Minor Health       Date:  2013-02

2.  Trends in age-standardised and age-specific mortality from ischaemic heart disease in Germany.

Authors:  Falk Müller-Riemenschneider; Frank Andersohn; Stefan N Willich
Journal:  Clin Res Cardiol       Date:  2010-03-24       Impact factor: 5.460

3.  Coronary artery calcium screening: current status and recommendations from the European Society of Cardiac Radiology and North American Society for Cardiovascular Imaging.

Authors:  Matthijs Oudkerk; Arthur E Stillman; Sandra S Halliburton; Willi A Kalender; Stefan Möhlenkamp; Cynthia H McCollough; Rozemarijn Vliegenthart; Leslee J Shaw; William Stanford; Allen J Taylor; Peter M A van Ooijen; Lewis Wexler; Paolo Raggi
Journal:  Eur Radiol       Date:  2008-07-24       Impact factor: 5.315

4.  PKPD modelling of the interrelationship between mean arterial BP, cardiac output and total peripheral resistance in conscious rats.

Authors:  N Snelder; B A Ploeger; O Luttringer; D F Rigel; R L Webb; D Feldman; F Fu; M Beil; L Jin; D R Stanski; M Danhof
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

5.  Effects of selective I f-channel inhibition with ivabradine on hemodynamics in a patient with restrictive cardiomyopathy.

Authors:  Philip Wenzel; Nico Abegunewardene; Thomas Münzel
Journal:  Clin Res Cardiol       Date:  2009-08-27       Impact factor: 5.460

6.  Ergo-anthropometric assessment.

Authors:  Alberto Morales Salinas; Antonio Coca
Journal:  Mayo Clin Proc       Date:  2009-10       Impact factor: 7.616

Review 7.  Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes.

Authors:  Richard Kones
Journal:  Vasc Health Risk Manag       Date:  2013-10-21

8.  Do cardiovascular disease risk prediction tools need to be updated in Europe?

Authors:  Ilker Tasci
Journal:  Intern Emerg Med       Date:  2011-06-11       Impact factor: 3.397

9.  Metabolic syndrome in people with schizophrenia: a review.

Authors:  Marc DE Hert; Vincent Schreurs; Davy Vancampfort; Ruud VAN Winkel
Journal:  World Psychiatry       Date:  2009-02       Impact factor: 49.548

10.  Lipid and C-reactive protein levels, cardiovascular disease risk factors and simvastatin treatment in Brazilian individuals.

Authors:  Alexandre B Rosendo; Luciana O Lima; Felipe Dal-Pizzol; Silvana Almeida
Journal:  Inflammation       Date:  2010-08       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.